Tag Archive: GlaxoSmithKline


Global Community Report Banner photo FSPLogoGlobalCommunityFulloldworldmapbckgrnd_zps43d3059c.jpg

Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg

……………………………………………………………………………….

 

Paxil

Paxil , Wkimedia.org

……….

 

By Kristen Anderson

The FDA requires each new drug to undergo rigorous testing and stand up to scientific scrutiny, a process that is designed to protect consumers by thoroughly examining the effects of new medications before they are available to the public. But few people stop to realize that these studies which are mandated by the FDA, are actually funded by the drug companies themselves, clearly a conflict of interest.

Big Pharma has so much influence in the field of scientific research, that the professionals who depend on peer-reviewed studies, i.e. doctors, psychiatrists, nurses, etc., prefer to read meta-analyses as a way to ensure objectivity. These meta-analyses combine evidence from multiple studies to weed out studies that produced irregular or uncommon results. In this way, the meta-analysis is regarded as the purest form of research and is heavily relied on by medical professionals. But, again, if Big Pharma has essentially infiltrated the research industry to the point that the majority of studies are being skewed, even a meta-analysis is unreliable.

Take for example Study 329. GlaxoSmithKline funded Study 329 between 1994 and 1998 and the results showed that Paxil was safe for teenagers. This study was published in 2001 in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), a well-respected and peer-reviewed journal. It was later found, however, that the authors had downplayed the negative findings and that GlaxoSmithKline had actually hired a PR firm to ghost write the article! Paxil actually clearly increases suicidal thoughts and impulses among teenagers and this effect was downplayed in the article and not even addressed in the conclusion (the most-read section of a scientific study).

 

Read More Here

Breaking Report: HPV Cancers Rising In Spite of Vaccination

A new study by the National Cancer Institute (NCI) reveals that, despite increasing uptake of human papillomavirus (HVP) vaccines, cancers linked to HPV rose in the past decade.

The report, published in the Journal of the National Cancer Institute, was co-authored by researchers from the American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR), and found that while overall cancer death rates in the U.S. continue to decline among both men and women over the past decade, incidence rates are actually increasing for HPV-associated oral, vulva and anal cancers.

As reported by Fierce Vaccines, this finding may “irk HPV vaccine makers Merck and GlaxoSmithKline,” whose vaccines have been adopted and lauded by national and global health authorities as safe and effective, ‘live saving’ interventions.

Obviously, if the report is correct, and by 2010 as many as 48.7 percent of girls ages 13 through 17 had received at least one dose of the HPV vaccine, and 32 percent received all three recommended doses, we should expect to find a widespread decline in HPV-associated cancers if the vaccines actually work as advertised.

Read More Here

Enhanced by Zemanta

 

First version of this article was originally published on 11 July, 2012


MessageToEagle.com – Scientists have made an unexpected and unsettling discovery – a large number of new and previously unseen mutations have been detected among humans.

There are those who suggest that there will soon be fantastic X-men among humans. These super earthlings do not come out of secret laboratories, as in famous blockbuster movies, but are born naturally. Other scientists are less optimistic and consider the unforeseen development can to lead to unknown changes in the human body.

This unexpected and terrifying discovery is a result of a study conducted by scientists from Cornell University (USA) and University of California.

When they examined genes of several thousands of people from around the world, it turned out that mankind has acquired over the past few years new, previously unseen mutations.

Is a new human race being born?

The scientist studied 202 genes in 14,002 people. The human genome contains some 3 billion base pairs; the scientists studied 864,000 of these pairs. While this is only a small part of the genome, the sample size of 14,002 people is one of the largest ever in a sequencing study in humans.

This project led by John Novembre of the University of California Los Angeles and Vincent Mooser of UK-based drug company GlaxoSmithKline, reports that more than 95% of variants found by sequencing 202 genes in 14,002 people were rare, and that 74% of the variants were carried by only one or two people in the study.

 

“I knew there would be rare variation but had no idea there would be so much of it!” said the senior author of the research, John Novembre, an assistant professor of ecology and evolutionary biology and of bioinformatics at UCLA.In the study, 10,621 people had one of 12 diseases, including coronary artery disease, multiple sclerosis, bipolar disorder, schizophrenia, osteoarthritis and Alzheimer’s disease; 3,381 did not have any of the diseases.

“The large sample size allows us to see patterns with more clarity than ever before,” Novembre said.

“If rare variants are like distant stars, this kind of large sample size is like having the Hubble Telescope; it’s allowing us to see more than before.

 

We see a ton of rare variation, and these rare variants more often make changes to proteins than not. In that way, this study has important implications for the genetic basis of disease in humans. It’s consistent with the idea that many diseases may be partly caused by rare variants.”

“Research carried out fifty years ago, showed that the mutant gene had only one man among a thousand, and now five people”, explained John Novembre.

What is causing the mutations?

Previously it was thought that genetic abnormalities are caused by of radiation, viruses, transposons and mutagenic chemicals, but now scientists have identified yet another factor that results in mutations – overpopulation!

Human population growth helps to explain the large number of genetic variants, the scientists said.

Mutations can cause unknown changes in the human body.

 

Read Full Article Here

Health And Wellness Report

by: Ethan A. Huff, staff writer
infants
(NaturalNews) The push is on to get as many newborn babies as possible vaccinated for rotavirus in the U.K., as health officials unveil a new vaccine program that they claim will reduce hospital admissions for the stomach bug. BBC News reports that the U.K. Department of Health will begin administering the oral drop-based vaccine Rotarix, which is manufactured by GlaxoSmithKline(GSK), to children beginning in September 2013, even though the controversial vaccine has previously been found to harbor viral fragments of a swine virus known as porcine circovirus 1, or PCV1.Following the lead of the U.S., Australia, and several other countries in Europe that have already adopted the use of Rotarix in small infants, British health officials are currently talking up the alleged benefits of the vaccine in order to gain public approval for its widespread introduction. According to official claims, the vaccine program, if implemented as intended, will cost the public health system in the U.K. the equivalent of nearly $40 million a year, while only purportedly saving it about $32 million a year.

But missing from the conversation is any talk about the very serious side effects of Rotarix, which just so happens to contain live attenuated virus. According to the U.S. Food and Drug Administration (FDA), infants given Rotarix are twice as likely to develop intussusception, a potentially-deadly medical condition in which the intestines become blocked (http://www.fda.gov). Based on the figures, the risk of dying from these vaccine complications is likely higher than the risk of dying from rotavirus, which is relatively low.

Beyond these direct side effects, it was uncovered back in 2010 that every batch of Rotarix ever produced since the vaccine’s initial introduction back in 2008 has been contaminated with viral genetic material of PCV1. As reported by the National Vaccine Information Center (NVIC) at that time, foreign DNA from this swine virus had apparently contaminated GSK’s working cell bank and viral “seed” stock long before the vaccine even hit the market, which means millions of children have potentially become exposed to this tainted vaccine material. (http://www.fda.gov)

According to the FDA’s website, neither the agency nor GSK know how foreign DNA from PCV1 came to be present in Rotarix in the first place, and the two entities are supposedly still “investigating this question.” Meanwhile, the Rotarix vaccine is still in widespread use, and health authorities are continuing to push parents to subject their young babies to this questionable vaccine that, at best, only helps reduce the number of days an infant suffers from diarrhea. With this in mind, do the risks of the vaccine truly outweigh its alleged benefits?

Sources for this article include:

http://www.bbc.co.uk/news/health-20268350

http://www.telegraph.co.uk

http://www.infowars.com

Learn more: http://www.naturalnews.com/038097_vaccines_infants_contamination.html#ixzz2DOPdp8nf

Health And Wellness Report

by: Jonathan Benson, staff writer
Gardasil
(NaturalNews) A recent study published in the open-access journal Pharmaceutical Regulatory Affairsprovides shocking new evidence that viral components contained in the human papillomavirus (HPV) vaccine Gardasil are capable of crossing the blood-brain barrier and triggering cerebral vasculitis, a severe form of blood vessel inflammation in the brain that can lead to severe autoimmune disorders and even death.A postmortem assessment of two young girls from opposite ends of the world who died recently after being given the Gardasil vaccine revealed fragments of the HPV-16L1 antigen, which is added to both Gardasil (Merck & Co.) and Cervarix (GlaxoSmithKline), inside the girls’ brain tissue. According to the study’s authors, these particles represent a genetic fingerprint of the Gardasil vaccine, which is now clearly exposed as causing serious, adverse events in at least some of the girls that receive it.

For their research, Dr. Chris Shaw from the University of British Columbia (UBC) in Canada and Dr. Lucija Tomljenovic from the Neural Dynamics Research Group in Vancouver examined samples of brain tissue taken from both girls, one 19 years old and the other 14 years old. Their analysis focused specifically on the potential presence of both HPV-16L1 and HPV-18L1, two specific antigens used in HPV vaccines.

Much to their surprise, the researchers observed that HPV-16L1 had bound itself to the walls of cerebral blood vessels in both of the girls’ brains. They also noticed increased T-cell signaling in both brain tissue samples, as well as the marked activation of the classical antibody-dependent complement pathway in the cerebral vascular tissues. Put more simply, viral components of Gardasil that never should have crossed over into the brain, were found to be fully capable of doing precisely this.

“[O]ur IHC (immunohistochemistry) analysis showed evidence of an autoimmune vasculitis potentially triggered by the cross-reactive HPV-16L1 antibodies binding to the wall of cerebral blood vessels in all examined brain samples,” says the study. “Our study suggests that HPV vaccines containing HPV-16L1 antigens pose an inherent risk for triggering potentially fatal autoimmune vasculopathies.”

Study offers definitive proof that Gardasil causes blood vessel inflammation in brain, which can lead to sudden death

Such findings are groundbreaking, as they illustrate for the first time in known history, according to the vaccine awareness group SaneVax, that a vaccine is directly linked to causing a serious, adverse event. And what better vaccine is there with which to make this discovery than Gardasil, which as of this writing has been linked to at least 27,485 adverse events, and at least 121 deaths.

Even though the sample size used in the study was small, and no control subjects used, the presence of Gardasil-specific components in the brain tissue of two different girls from opposite ends of the globe suggests the vaccine contains some type of driving mechanism by which these toxic components are able to be delivered directly into the brain. One major suspect is the aluminum adjuvant used in the vaccine, upon which HPV-16L1 and HPV-18L1 are adsorbed.

“For the average medical consumer, this evidence suggests that the antibodies produced in response to vaccination with the HPV-16L1 may cause one’s immune system to attack its own blood vessels,” wrote Norma Erickson, President of SaneVax, in a recent announcement about the study. “Given that the autopsy in both cases revealed no major abnormality (anatomically, microbiologically or toxicologically) that might have been regarded as a potential cause of death, it appears plausible that the antigenic component of the HPV vaccine (HPV-16L1) was indeed responsible for the fatal inflammation of the blood vessels.”

Sources for this article include:

http://sanevax.org

http://sanevax.org

http://www.naturalnews.com/Gardasil.html

Learn more: http://www.naturalnews.com/037959_Gardasil_girls_death.html#ixzz2CO7Ax6fp

Cloned horses may compete in the 2012 London Olympics, while anti-doping testing for humans becomes more sophisticated

By Simon Victor,

(NaturalNews) While performance enhancement drugs and techniques may be banned for humans, the gate has been opened for genetically modified horses to compete in the Olympic games.

In a surprising but not shocking development, the Federation Equestre Internationale has decided to overturn a ban previously placed on cloned equines.

According to The Chronicle of the Horse at their recently held sports forum it was said, “The FEI will not forbid participation of clones or their progenies in FEI competitions. The FEI will continue to monitor further research, especially with regard to equine welfare.”

Whereas in 2007, the stance of the FEI was the polar opposite; “The competitive equestrian couple of horse and rider are both acknowledged as athletes by the FEI. The cloning of either with a view to competing at international level would be unacceptable to the FEI. The FEI opposes cloning for it goes against one of the FEI’s basic objectives: to enable FEI athletes ‘to compete in international events under fair and even conditions.”

This announcement comes in light of the London 2012 Olympics being touted as having “the most sophisticated anti-doping operation in the history of the Games.” According to CNN, for the first time in Olympics history, a private company will provide its facilities – $30 million state-of-the-art laboratory – to aide in the testing of samples from Olympic participants to detect illegal performance enhancements. This is being provided by pharmaceutical giant GlaxoSmithKline (GSK). According to GSK, the facilities will offer “enable expert analysts from King’s (College, London) to independently operate a World Anti-Doping Agency (WADA) accredited laboratory during the Games.”

Although the FEI announcement has come too late for cloned horses to participate in the London 2012 Olympics, the implications will be far reaching, placing pressure on other equestrian governing bodies to relax the generally held stance of not allowing physiologically altering performance enhancement to be used by any participants.

This action has set a precedent for all sports, and the broader implications of such a development may mean that the rules pertaining to human performance enhancement may be contested, and become relaxed amid pressure from those who advocate its use.

Currently, the world’s biggest companies offering cloning are ViaTech in Texas and Cryozootech in Sonchamp, France.

They have both welcomed the news, and stated that their main aim is to allow the genes of top horses that have died or been gelded to be available again.

Sources for this article include:

http://www.chronofhorse.com

http://edition.cnn.com

http://www.gsk.com/media/london-2012/index.htm

About the author:
Simon Victor is a health health and fitness enthusiast who believes in being practical with healthy living.
his personal journey can be followed at http://veganonabudget.net

Published on Jul 16, 2012 by

This exclusive interview with former GlaxoSmithKline employee and whistleblower Blair Hamrick reveals insider details of GSK’s operations, for which the company recently pleaded guilty to felony crimes and paid a $3 billion settlement with the U.S. government.

In this Health Ranger Report video, Blair describes his firsthand knowledge of the “bribery” of physicians, the push for off-label marketing of drugs for unapproved health conditions, the illegal marketing of drugs to children, how 80 percent of physicians were willing to be “on the take,” and much more.

More details at NaturalNews.com

 

 

Drug Corporations Push Taliban Opium for Medical Use

Susanne Posel, Contributor
Activist Post

In 1998, scientists at Emory University in Atlanta, Georgia, discovered that noscapine could be used to combat tumors. Noscapine is derived from the opium poppy plant; the same source of heroin and the painkiller, morphine.

The drug version, called noscapine, is used as a cough suppressant in some countries. It is now being praised as a promising cancer-fighting agent.

Noscapine has been used in trial testing on animals and human cancer cells. It has proven to be effective in shrinking breast and prostate tumors; while possibly being a preventative for metastasis (the spread of tumors throughout the body).

The production of noscapine may prove difficult because of the labor-intensive methods used to extract the natural chemical. While industrial manufacturing of commercial opioids are froth with chemicals necessary to produce drugs, they are low on noscapine or are not present at all.

Since 1998, a new study by scientists at the University of York and funded by pharmaceutical giant GlaxoSmithKline, proves that synthetic noscapine (engineered opium) can be created by cross-breeding poppy plants and enhancing the production of noscapine by clustering together 10 genes responsible for its production.

Tim Bowser, co-author and lead researcher and developer for GlaxoSmithKline’s Australian opiates division said:

The fact that the genes are grouped in a cluster means that plant breeding becomes faster and easier. [We] are using this discovery to develop high-yielding commercial noscapine poppies in order to establish a reliable route of supply.

Australia produces large quantities of legal opioids. After negotiations in the ’60s and ’70s, the US government imports opium from Turkey for medical use.

The opium harvest fields in Afghanistan, controlled by the US military, are the perfect stores to obtain large amounts of poppy plants for study by drug corporations.

 

Most of the opium grown in Afghanistan is under the supervision of the Taliban and US troops in the region. While the Taliban has imposed a ban on opium production just after the US invaded Afghanistan in 2001, the Northern Alliance, which was supported by the US military, began protecting the fields where the raw production of opium was most prevalent.

The UN’s Office on Drugs and Crime oversee the UN’s Drug Control Program which estimates that in 2006, Afghanistan supplied 92% of the world’s opium.

In conjunction with the CIA, NATO and British military forces, Afghanistan has been forced to continue its opium growing operations.

Writer William Blum said:

CIA-supported Mujahedeen rebels [who in 2001 were part of the Northern Alliance] engaged heavily in drug trafficking while fighting against the Soviet-supported government and its plans to reform the very backward Afghan society.

However, the UN and WHO are more concerned with keeping the supply of opium flowing for “medical purposes” which is extremely profitable.

The World Health Organization (WHO) surmised that there is a severe shortage of opium-derived pain medications. The UN assumes Afghanistan could produce as estimated 4,200 tons of opium that WHO could be using to treat those patients in severe pain.

The discovery of synthetic opium could be the answer WHO was looking for.

Physicians have been using noscapine off-label to treat cancer because it is approved for use in some countries. Research data suggests noscapine could be a treatment for:

  • ovarian cancer
  • myeloma
  • lung cancer
  • colon cancer
  • breast and prostate tumors

In 2009, Johnson & Johnson purchased Cougar Biotechnology, a pharmaceutical corporation, with the express purpose of getting into the synthetic opium industry. They intended to cash in on the laboratory-created chemical and will push for more trials since the discovery of GlaxoSmithKline.

Susanne Posel is the Chief Editor of Occupy Corporatism. Our alternative news site is dedicated to reporting the news as it actually happens; not as it is spun by the corporately funded mainstream media. You can find us on our Facebook page.